These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7555190)

  • 1. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
    Chest; 1995 Oct; 108(4 Suppl):371S-379S. PubMed ID: 7555190
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in valvular heart disease.
    Stein PD
    Clin Geriatr Med; 2001 Feb; 17(1):163-72, viii. PubMed ID: 11270129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.
    Leiria TL; Lopes RD; Williams JB; Katz JN; Kalil RA; Alexander JH
    J Thromb Thrombolysis; 2011 May; 31(4):514-22. PubMed ID: 21327503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Dalen JE; Horstkotte D; Turpie AG
    Chest; 1998 Nov; 114(5 Suppl):602S-610S. PubMed ID: 9822066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Bussey HI; Dalen JE; Turpie AG
    Chest; 2001 Jan; 119(1 Suppl):220S-227S. PubMed ID: 11157651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is early antithrombotic therapy necessary in bioprosthetic valves?
    Mestres CA; Aramendi JI
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):724-5; author reply 725-6. PubMed ID: 20723739
    [No Abstract]   [Full Text] [Related]  

  • 7. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of patients with prosthetic heart valves].
    Jonkaitiene R; Benetis R; Eidukaityte R
    Medicina (Kaunas); 2005; 41(7):553-60. PubMed ID: 16062022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
    Chest; 1992 Oct; 102(4 Suppl):445S-455S. PubMed ID: 1395828
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
    Stein PD; Collins JJ; Kantrowitz A
    Chest; 1986 Feb; 89(2 Suppl):46S-53S. PubMed ID: 3510830
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
    Stein PD; Kantrowitz A
    Chest; 1989 Feb; 95(2 Suppl):107S-117S. PubMed ID: 2644093
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
    Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves.
    Yadlapati A; Groh C; Malaisrie SC; Gajjar M; Kruse J; Meyers S; Passman R
    Clin Res Cardiol; 2016 Mar; 105(3):268-72. PubMed ID: 26384981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.
    Sun JC; Davidson MJ; Lamy A; Eikelboom JW
    Lancet; 2009 Aug; 374(9689):565-76. PubMed ID: 19683642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
    Efthymiou CA; Mills RJ; O'Regan DJ
    J Card Surg; 2013 Nov; 28(6):723-9. PubMed ID: 23992398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal antithrombotic therapy for mechanical prosthetic heart valves.
    Chesebro JH; Fuster V
    Circulation; 1996 Nov; 94(9):2055-6. PubMed ID: 8901650
    [No Abstract]   [Full Text] [Related]  

  • 19. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.